4 Low Float Penny Stocks to Watch in the Last Week of March

low float penny stocks

After another massive drop on Monday, markets have now enjoyed two days of growth. Between yesterday and today, the Dow Jones has gained more than 3,000 points, while the S&P 500 gained 300. Is this a sign that the markets found their bottom on Monday and are now headed for stability or, dare I say, rebound? Time will tell, but no matter what the future holds at large, there will always be pockets of growth that smart investors can play in the near-term. Today, we’re listing some of the top low float penny stocks to keep on your radar.

Why Low Float Stocks?

We’ve already run down the biggest penny stock gainers of the month, as well as highlighted individual sectors like gold and healthcare that are soaring in the era of the coronavirus. All these picks are still worth watching, but looking at low float stocks is more important now than ever.

Low float stocks, as you likely already know, are companies with a low number of shares. These stocks are generally more susceptible to major swings in the market than a stock with a large float. This is because, with fewer available shares, buying or selling activity will have a more noticeable impact on the share price.

Seeing as the markets have been rapidly gaining these days, this is the time for low float penny stocks to shine. No doubt helping things is news of the incoming $2 trillion stimulus deal in the US. As the markets begin to look up, every one of our picks today is in the green by double digits.

However, present volatility means major downturns could still be just around the corner. These picks could potentially suffer major losses, so keep a close eye on them if you do take a position.

Low Float Penny Stocks to Watch: Astrotech Corp (NASDAQ:ASTC)

Astrotech Corp is a technology development and commercialization company. Its focus is on launching, managing, and building scalable companies that are based on innovative technology.

>> 4 Healthcare Penny Stocks to Watch This Week

Earlier today, shares of ASTC skyrocketed on the news that Astrotech is developing a breath test to screen for lung infections. Notably, that includes the COVID-19 virus and its resulting pneumonia. The company believes its offering can be used at drive-up testing facilities to detect the virus. It would potentially do this in less than a minute, with minimal training required for the administer.

Before the announcement was made, ASTC was trading at $1.12. The stock quickly reached a high of $7.75 before consolidating to its current price of $5.11. This represents 356.25% gains for the day, making it one of the biggest winners of March 25.

The company has 6.55 million shares out and a 3.98 million float. According to its Q2 fiscal earnings report, published on February 13, the Chairman and CEO of ASTC invested $1 million in the company within the last month and a half, bringing his total recent investments to $5.5 million.

Low Float Penny Stocks to Watch: BroadVision Inc (NASDAQ:BVSN)

low float penny stocks

BroadVision is an international software company that provides self-service web applications for online businesses. Its solutions are available globally in the cloud and include enterprise social software, electronic commerce, and customer relationship management.

The company saw massive gains today as BroadVision announced it is making its Telework Jumpstart Program (TJP) immediately available to the public. This program allows users to freely access the Vmoso enterprise digital hub platform, which—similar to messaging platform Slack—enables an organization’s workforce to collaborate online.

The timing of the release is to empower businesses during the self-quarantine widely imposed to fight the COVID-19 outbreak. BroadVision’s General Manager of Global Operations, Yun-Ping Hsu, explains:

“By unifying social collaboration, file sharing, task management, knowledge management capabilities, together with email and teleconferencing integration, Vmoso users can get more work done with less, at any time, from anywhere, while turning today’s conversations into tomorrow’s knowledge, automatically.”

BVSN stock leaped 79.72% on the news, rising from $1.66 to $2.99. Over the last year, the company successfully reduced its exorbitant cash burn by 53%, though its operating revenue remains flat.

BroadVision currently has 5.06 million shares outstanding and a 1.67 million float. According to MarketBeat, BVSN has seen $428,000 worth of insider trading this quarter.

Low Float Penny Stocks to Watch: Happiness Biotech Group Ltd (NASDAQ:HAPP)

Located in Nanping, China, Happiness Biotech Group produces nutraceutical and dietary supplements. The company’s focus is to research, develop, manufacture, and market a variety of products made from Chinese herbal extracts.

Founded in 2006, Happiness Biotech has since established a product portfolio of 32 CFDA-registered “Blue-Cap” supplement products.

>> 5 Penny Stock Gainers to Watch

Earlier today, the company announced a “breakthrough” in developing testing kits for COVID-19. In collaboration with Fuzhou University, Happiness successfully developed a “colloidal gold testing kit,” which detects the virus through the presence of antibodies.

Currently, the average test—achieved through nucleic acid detection—takes five to six hours. In addition, both the misdetection rate and the cost of the test remain high. Happiness, however, claims that its test is both affordable and has a greatly improved detection sensitivity. The test also reportedly brings detection time down to 10 to 15 minutes.

Happiness Biotech CEO, Xuezhu Wang, says the company is “ready to submit the CFDA certification application next week.” He expects to receive approval quickly, as the CFDA—similar to the FDA—has an emergency approval mechanism in place.

This morning, HAPP exploded from $2.52 to its current price of $3.55. That’s a gain of 40.48%, and the stock is still trading up as of this writing. The company has 23.89 million shares issued and outstanding, and a float of 9.23 million.

Low Float Penny Stocks to Watch: Acer Therapeutics Inc (NASDAQ:ACER)

low float penny stocks

Acer Therapeutics is a pharmaceutical company that focuses on acquiring, developing, and commercializing therapies for serious rare and life-threatening diseases with significant unmet medical needs. The company currently has three drug candidates in the commercial-stage.

On March 18, the company announced that the FDA’s Office of New Drugs (OND) denied a recent appeal that Acer submitted. The company was appealing to receive a positive reply to its New Drug Application (NDA) for one of its proprietary therapeutics, EDSIVO.

When the news first broke last Wednesday, ACER shares were hit hard. The stock dropped from $2.69 to $1.30. This week, though, the shares price rebounded 47%, reaching $1.97.

In its denial letter to the appeal, the OND detailed certain paths forward that Acer can take to resubmit its NDA for EDSIVO. According to Chris Schelling, CEO and Founder of the company, Acer will be “evaluating [its] possible next steps with the goal of resubmission of the EDSIVO NDA.”

The company remains confident that its current cash position is sufficient to fund operations through the end of 2020. According to Acer’s fourth-quarter and full-year fiscal results, published the same day as the announcement, it ended Q4 with $12.1 million in cash and cash equivalents.

Acer Therapeutics has 14.68 shares issued and outstanding and a float of 7.49 million. According to MarketBeat, the last significant insider trade occurred in Q3 2018, when a Director purchased $4,95 million worth of stock.

Takeaway

Today’s list shares some names with the top momentum penny stocks. This goes to show how quick a low float penny stock can pick up. That is especially true when a lot of capital is re-entering the markets, as we’ve seen all this week.

Remember to do your own research into these picks before investing. And watch them closely, as there’s no telling for certain where they’ll go from here.

>> Read More Penny Stock News

Featured image: DepositPhotos © koydesign

Please See Disclaimer


Risks and Disclosure:

Information provided in this correspondence is intended solely for informational purposes and is obtained from sources believed to be reliable. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained on this website is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between any predictions made or suggested and the actual results.

All statements and opinions expressed are the opinions of the author and not of Microsmallcap.com or its officers. The author is wholly responsible for the validity of all statements. Microsmallcap.com was not involved in any aspect of the article preparation. The author was not paid by Market Jar Media Inc for this article. The author did not pay Microsmallcap.com to publish or syndicate this article.

This article does not constitute as investment advice. Each reader is encouraged to consult with his or her individual financial advisor; any and all actions taken by a reader as a result of the information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Microsmallcap.com's terms of use and full legal disclaimer. This article is in no way a solicitation for investment. Microsmallcap.com does not render general or specific investment advice. Any information on Microsmallcap.com should not be considered a recommendation to buy or sell any security. Microsmallcap.com does not endorse or recommend the business, products, services or securities of any company mentioned on Microsmallcap.com.

Futures, stocks and options trading involves substantial risk of loss and is not suitable for every investor. The valuation of futures, stocks, and options may fluctuate, and, as a result, clients may lose more than their original investment and possibly their entire investment. Any content on this website should not be relied upon as advice or construed as providing recommendations of any kind. It is your responsibility to confirm and decide which trades to make. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.

Please see our full disclaimer here for additional details before making any investment decisions.